Consistent with these animal experiments, studies in human diabetic nephropathy showed that the ACE inhibitor, perindopril was able to reduce TGF-ß mRNA in a sequential renal biopsy study [47] and the ARB, losartan, was shown to lower urinary TGF-ß excretion [48]. Here, ACE is linked to diabetic kidney disease.